Meet the 24-year-old helping Lilly test a preventive Alzheimer’s drugBy Press Room6 February 2025 Hannah Richardson, 24, undergoes a brain scan as part of the Primary Prevention Trial for Alzheimer’s disease led by Washington…
Hate needles? Lilly’s weight-loss pill could get FDA approval next year, CEO saysBy Press Room22 January 2025 Eli Lilly & Co., the Fortune 500 pharma firm that manufactures weight-loss injection Zepbound (tirzepatide), has a comparable oral medication…
Weight Loss Pills Intensify Obesity Drug Race—But Here’s Why Experts Say Injections Aren’t Going AnywhereBy Press Room19 July 2024 Topline Competition in the race to crack the lucrative weight loss drug market is heating up as rivals like Roche,…
Asthma Drug Xolair Now Indicated For Food Allergies: Next Challenge Is Insurer CoverageBy Press Room6 March 2024 Two weeks ago, the Food and Drug Administration approved Xolair (omalizumab) for immunoglobulin E-mediated food allergy in certain adults and…